Literature DB >> 35119383

Crystallographic hallucinations.

Brian H Toby1.   

Abstract

Entities:  

Keywords:  Rietveld; pharmaceutical; psilocybin; psychedelic; quantitative phase analysis

Mesh:

Year:  2022        PMID: 35119383      PMCID: PMC8815676          DOI: 10.1107/S2053229622000511

Source DB:  PubMed          Journal:  Acta Crystallogr C Struct Chem        ISSN: 2053-2296            Impact factor:   1.172


× No keyword cloud information.
Psilocybin was of great inter­est to some of my contemporaries during my student days, but not due to its crystal structure, at least not directly. At present, due to the study of hallucinogens as possible treatment agents for various mental illnesses, their use has become a topic of significantly renewed inter­est (Gill et al., 2020 ▸; Sherwood & Prisinzano, 2018 ▸). As is well known in the pharmaceutical industry, crystallographic characterization of materials is crucial in order to understand the bioavailability of a drug (Byrn et al., 1999 ▸). Structural knowledge is thus highly important for the potential use of psilocybin. In their detailed study of the structural forms of psilocybin reported recently in Acta Crystallographica Section C, Sherwood et al. (2022 ▸) solve two novel anhydrous psilocybin structures ab initio from high-resolution synchrotron and from laboratory X-ray powder data, respectively. While attempts to directly crystallize the anhydrous forms were attempted, they could only produce the phases by removing water from a hydrated form. The hydrated phase forms single crystals and has a determined structure, but dehydration destroys these crystals, producing crystalline powders. To confirm the quality of the powder structures and review the hydrogen-bonding motifs, they performed computations with plane-wave density functional theory (DFT). A second form of DFT was used in ‘gas phase’ computations to compare the energetics of the psilocybin conformations for isolated mol­ecules for their two new polymorphs and the previously-known hydrated form. While the very high quality of the fits between the observed and calculated patterns would already give one confidence in their results, their verification that that calculations from theory demonstrate that the structures represent energetic minima boosts confidence in their results manyfold. However, it had been reported in the patent literature that different polymorphs exist. To address this, Sherwood et al. (2022 ▸) performed Rietveld fits on data from a total of 24 different samples, either with contemporary data collection or with digitized powder diffraction patterns taken from the literature. They show that all these patterns are consistent with their two new anhydrous structures and the known hydrous form, sometimes as mixtures and sometimes where intensities require correction for significant preferred orientation. This texture is not at all surprising considering the highly anisotropic crystal habits they see in the powders. Furthermore, they made significant efforts to coax psilocybin to crystallize in other structural forms, but to no avail. Based on all this, the previous assignment of other phases for anhydrous psilocybin seems highly unlikely and this careful work casts doubt that any other anhydrous polymorphs could exist. This tour de force study is one that deserves exposure in the classroom, so that crystallography students may see how powder diffraction crystallography can rise to the gold standard level that we expect from single-crystal analysis. In fact, it is worth noting that the agreement seen between DFT and the powder–synchrotron structure is far better than the DFT–single crystal agreement. The impact of this work on patents issued with incorrect crystallography is something to be resolved in courts, not the scientific literature, but I have no doubt that a number of scientific managers are currently considering the potential impact that less-than-careful crystallography might have on their organization’s intellectual property collections. The compelling structural validation work by Sherwood et al. (2022 ▸) demonstrates the great value of DFT as a partner tool to crystallography. As I write this, on the eve of International Holocaust Remembrance Day, thinking about DFT raises for me thoughts on another topic of contemporary worldwide interest – if not contention – which is on the value in opening borders for immigration. It is worth remembering that the life of Walter Kohn, who won the Nobel Prize for his development of DFT, was saved by the British Kindertransport, which resettled children in the UK even when their parents could not cross borders. As a child, Walter and his sister Minna were able to leave Austria for Britain and thus survived World War II. Walter was educated in Canada and eventually immigrated to the United States. Walter’s work gave the world this highly useful approach to quantum theory, but he never saw his parents again; they died in Auschwitz (Kohn, 1998 ▸; https://www.notablebiographies.com/supp/Supplement-Ka-M/Kohn-Walter.html). As a final point, with the ubiquitous availability of fast computers and with easier to learn codes (some open source), DFT is an increasingly accessible tool for crystallographers. Even with a good-quality single-crystal structure, verification of hydrogen-bonding networks is a worthwhile exercise. With powder diffraction crystallography, structural validation becomes even more valuable.
  3 in total

1.  Novel psychotherapeutics - a cautiously optimistic focus on Hallucinogens.

Authors:  Alexander M Sherwood; Thomas E Prisinzano
Journal:  Expert Rev Clin Pharmacol       Date:  2017-12-17       Impact factor: 5.045

Review 2.  The emerging role of psilocybin and MDMA in the treatment of mental illness.

Authors:  Hartej Gill; Barjot Gill; David Chen-Li; Sabine El-Halabi; Nelson B Rodrigues; Danielle S Cha; Orly Lipsitz; Yena Lee; Joshua Daniel Rosenblat; Amna Majeed; Rodrigo B Mansur; Flora Nasri; Roger Ho; Roger S McIntyre
Journal:  Expert Rev Neurother       Date:  2020-09-30       Impact factor: 4.618

3.  Psilocybin: crystal structure solutions enable phase analysis of prior art and recently patented examples.

Authors:  Alexander M Sherwood; Robert B Kargbo; Kristi W Kaylo; Nicholas V Cozzi; Poncho Meisenheimer; James A Kaduk
Journal:  Acta Crystallogr C Struct Chem       Date:  2022-01-01       Impact factor: 1.172

  3 in total
  1 in total

1.  The crystal structure of baeocystin.

Authors:  Marilyn Naeem; Alexander M Sherwood; Andrew R Chadeayne; James A Golen; David R Manke
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2022-05-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.